HHLA2 checkpoint inhibitor (Conformation-X Therapeutics)

N/A

Report date: 2025/06/11 10:53:12

Base Information

Drug NameHHLA2 checkpoint inhibitor (Conformation-X Therapeutics)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionHERV-H LTR-associating protein 2 inhibitorsT lymphocytes stimulantsImmunostimulants
TargetsHERV-H LTR-associating protein 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesConformation-X Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesConformation-X Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A